Dynamic control of Th2 cell responses by STAT3 during allergic lung inflammation in mice

International Immunopharmacology

Volumn 28, Issue 2, 2015, Pages 846-853

  Lim, Hoyong ^a   Cho, Minkyoung ^a   Choi, Garam ^a   Na, Hyeongjin ^a   Chung, Yeonseok ^a  

^a Seoul National University   (South Korea)

Author keywords

Allergic asthma; STAT3; Th1 cell; Th17 cell; Th2 cell

Indexed keywords

ALLERGEN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; STAT3 PROTEIN; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; CYTOKINE; FUNGUS ANTIGEN; OVALBUMIN; PEPTIDE HYDROLASE; STAT3 PROTEIN, MOUSE;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOREGULATION; LUNG LAVAGE; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; ASPERGILLUS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; CELL COUNT; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; PATHOLOGY;

ALLERGENS; ANIMALS; ANTIGENS, FUNGAL; ASPERGILLUS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CELL DIFFERENTIATION; CYTOKINES; DISEASE MODELS, ANIMAL; LUNG; LYMPH NODES; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; PEPTIDE HYDROLASES; STAT3 TRANSCRIPTION FACTOR; TH17 CELLS; TH2 CELLS;

EID: 84948571982     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.03.051     Document Type: Article

References (58)

1. J. Zhao, C.M. Lloyd, and A. Noble Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling Mucosal Immunol. 6 2013 335 346
2. W.W. Busse, and R.F. Lemanske Jr. Asthma N. Engl. J. Med. 344 2001 350 362
3. W. Eder, M.J. Ege, and E. von Mutius The asthma epidemic N. Engl. J. Med. 355 2006 2226 2235
4. N. Pearce, N. Ait-Khaled, R. Beasley, J. Mallol, U. Keil, E. Mitchell, and et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC) Thorax 62 2007 758 766
5. L. Cosmi, F. Liotta, E. Maggi, S. Romagnani, and F. Annunziato Th17 cells: new players in asthma pathogenesis Allergy 66 2011 989 998
6. S. Saglani, S.A. Mathie, L.G. Gregory, M.J. Bell, A. Bush, and C.M. Lloyd Pathophysiological features of asthma develop in parallel in house dust mite-exposed neonatal mice Am. J. Respir. Cell Mol. Biol. 41 2009 281 289
7. S.T. Holgate Innate and adaptive immune responses in asthma Nat. Med. 18 2012 673 683
8. R.K. Kumar, C. Herbert, D.C. Webb, L. Li, and P.S. Foster Effects of anticytokine therapy in a mouse model of chronic asthma Am. J. Respir. Crit. Care Med. 170 2004 1043 1048
9. S. Schnyder-Candrian, D. Togbe, I. Couillin, I. Mercier, F. Brombacher, V. Quesniaux, and et al. Interleukin-17 is a negative regulator of established allergic asthma J. Exp. Med. 203 2006 2715 2725
10. C. Doe, M. Bafadhel, S. Siddiqui, D. Desai, V. Mistry, P. Rugman, and et al. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD Chest 138 2010 1140 1147
11. C.M. Lloyd, and E.M. Hessel Functions of T cells in asthma: more than just T(H)2 cells Nat. Rev. Immunol. 10 2010 838 848
12. G. Grunig, M. Warnock, A.E. Wakil, R. Venkayya, F. Brombacher, D.M. Rennick, and et al. Requirement for IL-13 independently of IL-4 in experimental asthma Science 282 1998 2261 2263
13. J.F. Alcorn, C.R. Crowe, and J.K. Kolls TH17 cells in asthma and COPD Annu. Rev. Physiol. 72 2010 495 516
14. Y. Souwer, K. Szegedi, M.L. Kapsenberg, and E.C. de Jong IL-17 and IL-22 in atopic allergic disease Curr. Opin. Immunol. 22 2010 821 826
15. E.L. van Rensen, K.C. Straathof, M.A. Veselic-Charvat, A.H. Zwinderman, E.H. Bel, and P.J. Sterk Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma Thorax 54 1999 403 408
16. H. Bisgaard, M.N. Hermansen, L. Loland, L.B. Halkjaer, and F. Buchvald Intermittent inhaled corticosteroids in infants with episodic wheezing N. Engl. J. Med. 354 2006 1998 2005
17. W. Mattos, S. Lim, R. Russell, A. Jatakanon, K.F. Chung, and P.J. Barnes Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids Chest 122 2002 1543 1552
18. L. Todorova, E. Gurcan, G. Westergren-Thorsson, and A. Miller-Larsson Budesonide/formoterol effects on metalloproteolytic balance in TGFbeta-activated human lung fibroblasts Respir. Med. 103 2009 1755 1763
19. P.J. Barnes, and I.M. Adcock How do corticosteroids work in asthma? Ann. Intern. Med. 139 2003 359 370
20. G. Caramori, and I. Adcock Pharmacology of airway inflammation in asthma and COPD Pulm. Pharmacol. Ther. 16 2003 247 277
21. Y. Morishima, S. Ano, Y. Ishii, S. Ohtsuka, M. Matsuyama, M. Kawaguchi, and et al. Th17-associated cytokines as a therapeutic target for steroid-insensitive asthma Clin. Dev. Immunol. 2013 2013 609395
22. P. Nair, M.M. Pizzichini, M. Kjarsgaard, M.D. Inman, A. Efthimiadis, E. Pizzichini, and et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia N. Engl. J. Med. 360 2009 985 993
23. L. McKinley, J.F. Alcorn, A. Peterson, R.B. Dupont, S. Kapadia, A. Logar, and et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice J. Immunol. 181 2008 4089 4097
24. J.L. Simpson, R. Scott, M.J. Boyle, and P.G. Gibson Inflammatory subtypes in asthma: assessment and identification using induced sputum Respirology 11 2006 54 61
25. G.P. Anderson Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease Lancet 372 2008 1107 1119
26. L.C. Borish, H.S. Nelson, J. Corren, G. Bensch, W.W. Busse, J.B. Whitmore, and et al. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma J. Allergy Clin. Immunol. 107 2001 963 970
27. G. Pelaia, A. Vatrella, and R. Maselli The potential of biologics for the treatment of asthma Nat. Rev. Drug Discov. 11 2012 958 972
28. J. Corren, R.F. Lemanske, N.A. Hanania, P.E. Korenblat, M.V. Parsey, J.R. Arron, and et al. Lebrikizumab treatment in adults with asthma N. Engl. J. Med. 365 2011 1088 1098
29. P. Flood-Page, C. Swenson, I. Faiferman, J. Matthews, M. Williams, L. Brannick, and et al. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma Am. J. Respir. Crit. Care Med. 176 2007 1062 1071
30. H.Y. Kim, R.H. DeKruyff, and D.T. Umetsu The many paths to asthma: phenotype shaped by innate and adaptive immunity Nat. Immunol. 11 2010 577 584
31. P. Miossec, and J.K. Kolls Targeting IL-17 and TH17 cells in chronic inflammation Nat. Rev. Drug Discov. 11 2012 763 776
32. W.W. Busse, S. Holgate, E. Kerwin, Y. Chon, J. Feng, J. Lin, and et al. Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma Am. J. Respir. Crit. Care Med. 188 2013 1294 1302
33. P. Rich, B. Sigurgeirsson, D. Thaci, J.P. Ortonne, C. Paul, R.E. Schopf, and et al. Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study Br. J. Dermatol. 168 2013 402 411
34. L. Cosmi, L. Maggi, V. Santarlasci, M. Capone, E. Cardilicchia, F. Frosali, and et al. Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4 J. Allergy Clin. Immunol. 125 2010 (222-30 e1-4)
35. Y.H. Wang, K.S. Voo, B. Liu, C.Y. Chen, B. Uygungil, W. Spoede, and et al. A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma J. Exp. Med. 207 2010 2479 2491
36. N.B. Marshall, and S.L. Swain Cytotoxic CD4 T cells in antiviral immunity J. Biomed. Biotechnol. 2011 2011 954602
37. G.L. Stritesky, R. Muthukrishnan, S. Sehra, R. Goswami, D. Pham, J. Travers, and et al. The transcription factor STAT3 is required for T helper 2 cell development Immunity 34 2011 39 49
38. J.P. Ray, H.D. Marshall, B.J. Laidlaw, M.M. Staron, S.M. Kaech, and J. Craft Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells Immunity 40 2014 367 377
39. J.J. O'Shea, and R. Plenge JAK and STAT signaling molecules in immunoregulation and immune-mediated disease Immunity 36 2012 542 550
40. J.E. Darnell Jr., I.M. Kerr, and G.R. Stark Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 264 1994 1415 1421
41. W.J. Leonard, and J.J. O'Shea Jaks and STATs: biological implications Annu. Rev. Immunol. 16 1998 293 322
42. J.J. O'Shea, and P.J. Murray Cytokine signaling modules in inflammatory responses Immunity 28 2008 477 487
43. X.O. Yang, A.D. Panopoulos, R. Nurieva, S.H. Chang, D. Wang, S.S. Watowich, and et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells J. Biol. Chem. 282 2007 9358 9363
44. M. Afkarian, J.R. Sedy, J. Yang, N.G. Jacobson, N. Cereb, S.Y. Yang, and et al. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4 + T cells Nat. Immunol. 3 2002 549 557
45. A.A. Lighvani, D.M. Frucht, D. Jankovic, H. Yamane, J. Aliberti, B.D. Hissong, and et al. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells Proc. Natl. Acad. Sci. U. S. A. 98 2001 15137 15142
46. J. Cote-Sierra, G. Foucras, L. Guo, L. Chiodetti, H.A. Young, J. Hu-Li, and et al. Interleukin 2 plays a central role in Th2 differentiation Proc. Natl. Acad. Sci. U. S. A. 101 2004 3880 3885
47. N. Mari, M. Hercor, S. Denanglaire, O. Leo, and F. Andris The capacity of Th2 lymphocytes to deliver B-cell help requires expression of the transcription factor STAT3 Eur. J. Immunol. 43 2013 1489 1498
48. H. Lim, Y.U. Kim, S.M. Drouin, S. Mueller-Ortiz, K. Yun, E. Morschl, and et al. Negative regulation of pulmonary Th17 responses by C3a anaphylatoxin during allergic inflammation in mice PLoS One 7 2012 e52666
49. H. Lim, Y.U. Kim, K. Yun, S.M. Drouin, and Y. Chung Distinct regulation of Th2 and Th17 responses to allergens by pulmonary antigen presenting cells in vivo Immunol. Lett. 156 2013 140 148
50. S. Oki, N. Otsuki, T. Kohsaka, and M. Azuma Stat6 activation and Th2 cell differentiation [correction of proliferation] driven by CD28 [correction of CD28 signals] Eur. J. Immunol. 30 2000 1416 1424
51. A.L. Wurster, T. Tanaka, and M.J. Grusby The biology of Stat4 and Stat6 Oncogene 19 2000 2577 2584
52. J. Zhu, L. Guo, C.J. Watson, J. Hu-Li, and W.E. Paul Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion J. Immunol. 166 2001 7276 7281
53. F.D. Finkelman, S.P. Hogan, G.K. Hershey, M.E. Rothenberg, and M. Wills-Karp Importance of cytokines in murine allergic airway disease and human asthma J. Immunol. 184 2010 1663 1674
54. D.M. Bullens, E. Truyen, L. Coteur, E. Dilissen, P.W. Hellings, L.J. Dupont, and et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir. Res. 7 2006 135
55. D. Mucida, and S. Salek-Ardakani Regulation of TH17 cells in the mucosal surfaces J. Allergy Clin. Immunol. 123 2009 997 1003
56. S. Oh, and E.S. Hwang The role of protein modifications of T-bet in cytokine production and differentiation of T helper cells J. Immunol. Res. 2014 2014 589672
57. C.M. Evans, and R.G. Jenner Transcription factor interplay in T helper cell differentiation Brief. Funct. Genomics 12 2013 499 511
58. K.J. Oestreich, and A.S. Weinmann T-bet employs diverse regulatory mechanisms to repress transcription Trends Immunol. 33 2012 78 83